Relay TherapeuticsÂ Inc (RLAY) Financials

$18.89

$0.23 (1.23%)

As on 10-Sep-2026 16:00EDT

Market cap

$4,172 Mln

Revenue (TTM)

$10 Mln

P/E Ratio

--

P/B Ratio

4.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	10.35	15.36	10.01	25.55	1.38	3.03
Cost of Revenue	68.99	3.56	315.44	326.39	243.01	169.39
Gross Profit	-58.64	11.80	-305.43	-300.84	-241.62	-166.36
Operating Expenses	251.79	314.54	67.03	72.16	57.65	198.34
Operating Profit (EBIT)	-310.44	-302.74	-372.47	-373.00	-299.28	-364.70
Other Income	--	--	--	--	8.79	0.83
Profit before Tax	-286.04	-276.48	-337.71	-341.97	-290.51	-363.87
Provision for Tax	--	--	-337.71	-37.47	-36.25	132.94
Profit after Tax (Net Income)	-286.04	-276.48	-337.71	-341.97	-290.51	-363.87
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-290.51	-363.87

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	890.01	567.06	777.79	752.00	950.22	897.81
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	26.64	28.69	42.78	61.71	85.84	86.31
Current Liabilities	50.80	25.58	50.73	30.27	63.71	24.32
Total Liabilities	1,018.26	621.33	871.30	843.98	1,099.77	1,008.44

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	39.38	43.05	62.09	73.88	80.27	32.20
Current Assets	928.08	578.28	809.20	770.10	1,019.51	976.24
Total Assets	1,018.26	621.33	871.30	843.98	1,099.77	1,008.44
Total Debt*	30.66	32.46	48.50	53.47	57.74	22.90
Net Current Assets	877.28	552.70	758.48	739.83	955.80	951.92

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-235.46	-249.11	-300.32	-229.49	-74.41
Cash Flow from Investing Activities	--	192.80	-41.08	257.63	-188.75	-479.51
Cash from Financing Activities	--	1.60	270.15	34.75	289.91	388.09
Net Cash Inflow / Outflow	--	--	--	--	-128.33	-165.83

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.57	-1.61	-2.02	-2.79	-2.40	-3.54
Cash EPS ($)	--	-1.59	-1.99	-2.75	-2.37	-3.50
Adjusted Book Value ($)	--	3.30	4.65	6.13	7.86	8.74
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.37	-1.49	-2.45	-1.90	-0.72
Free Cash Flow per Share ($)	--	-1.37	-1.50	-2.48	-1.97	-0.76

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-38.78	-41.39	-37.72	-30.13	-42.60
ROE (%)	-39.26	-41.12	-44.15	-40.18	-31.44	-43.81
ROA (%)	-32.15	-37.05	-39.38	-35.19	-27.56	-40.25
EBIT Margin (%)	-2,763.64	-1,800.58	-3,854.04	-1,485.25	-22,516.44	-7,494.45
Net Margin (%)	-2,763.64	-1,800.58	-3,374.72	-1,338.66	-2,857.37	-9,438.96
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	23.86	0.53	-0.61	17.50	-0.54	-0.96
EBIT Growth (%)	8.19	28.31	-1.65	-22.02	-36.98	-306.85
Net Profit Growth (%)	8.19	18.13	1.25	-17.72	20.16	-594.25
EPS Growth (%)	19.43	0.20	0.28	-0.16	0.32	-5.09
Book Value Growth (%)	12.89	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-5.25	-2.04	-3.95	-6.22	-8.67
Price / Book Value	4.56	2.56	0.89	1.79	1.90	3.51
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.80	-3.41	0.11	-1.75	-2.82	-9.95
Close Price ($)	18.71	8.46	4.12	11.01	14.94	30.71
High Price ($)	19.93	9.04	12.14	23.18	35.36	64.37
Low Price ($)	3.03	1.78	4.01	5.95	12.65	25.72
Market Cap ($ Cr)	4,172.46	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.06	0.06	0.07	0.06	0.03
Short term debt to equity ratio	0.00	0.01	0.01	0.01	0.00	0.00
Current Ratio	18.27	22.61	15.95	25.44	16.00	40.14
Quick Ratio	18.27	--	--	--	15.81	68.20
Interest Coverage	--	--	--	--	-35.47	-274.83

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	377.91	163.09
Asset Turnover	0.01	0.02	0.01	0.03	0.00	0.00
Receivable days	--	--	--	37.31	1,343.44	5,281.23
Inventory Days	--	--	--	13.55	-503.81	-992.50
Payable days	--	1,119.37	13.49	11.07	14.17	15.77
Cash Conversion Cycle	--	--	--	39.79	825.46	4,272.96

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.